BRASILIA (Reuters) – Brazilian pharmaceutical company Uniao Quimica plans to start producing Russia’s Sputnik V vaccine for COVID-19 in Brazil as soon as next week and build up to 8 million doses a month, its international business director Rogerio Rosso said on Friday.
The private company, with a vaccine facility in Brasilia, is preparing to request emergency use authorization from health regulator Anvisa for the vaccine developed in Moscow.
(Reporting by Anthony Boadle; Editing by Leslie Adler)
